AssayQuant Technologies Revenue and Competitors

We are a Life Science company developing innovative enzyme assay formats for a quantum improvement in performance and productivity. Our PhosphoSens® next generation Sox-based sensor platform uses proprietary technology invented in the Imperiali laboratory at MIT and is exclusively licensed to AssayQuant®. This format provides a simple and powerful solution to quantitatively measure the activity of protein kinases and phosphatases, with specificity for Tyr, Ser/Thr, or Mixed Function, using a direct, one-step homogeneous and continuous (kinetic) format. Samples can be recombinant or immunoprecipitated enzymes or crude cell or tissue lysates and assays can be read on commonly available microplate readers. This platform is ideal for elucidating drug mechanism of action, profiling and potency assessments. With multiple formats including PhosphoSens®, PhosphoSens®-Lysate and PhosphoSens®-Red and the ability to target different enzyme classes, our technologies are being applied across the discovery and drug development workflow to characterize next generation enzyme inhibitors and activators. Contact us today to learn how our Catalog products and Custom Assay Development or Testing Services can enable your efforts.